Journal of the American Chemical Society · 2009 · 55 citations · 36 references
PharmacyChemistryMedicinal ChemistryCancer PharmacologyCatalysisSynthetic Medicinal ChemistryCatalytic MechanismsMacrocycle SynthesisMarine Drug DiscoveryMicrotubule-targeting AgentsNatural Product-based Drug DesignRetrosynthetic AnalysisMacrocycle DiversificationMacrocycle Library SynthesisNatural Product Microtubule InhibitorsNatural Product PharmacologyNatural Product SynthesisSynthetic Microtubule-targeting AgentsSynthetic Route OptimizationTransition-metal-catalyzed Functionalization
Laulimalide is a structurally unique 20-membered marine macrolide displaying microtubule stabilizing activity similar to that of paclitaxel and the epothilones. The use of atom-economical transformations such as a Rh-catalyzed cycloisomerization to form the endocyclic dihydropyran, a dinuclear Zn-catalyzed asymmetric glycolate aldol reaction to prepare the syn 1,2-diol, and an intramolecular Ru-catalyzed alkene-alkyne coupling to build the macrocycle enabled us to synthesize laulimalide via an efficient and convergent pathway. The designed synthetic route also allowed us to prepare an analogue of the natural product that possesses significant cytotoxic activity.
36
The Atom Economy—A Search for Synthetic Efficiency
Paul R. Blakemore, W.J. Cole, Philip Kocieński et al. · Synlett · 1998 · 698 citations
Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
Susan L. Mooberry, Georgia Tien, A H Hernandez et al. · PubMed · 1999 · 330 citations
Medicine, Oncology, Pharmacology +15